The company expands the product lines and services it offers by developing and commercializing its own technologies and by making strategic acquisitions of complementary businesses. The company's strategy is to augment internal growth at existing businesses with complementary acquisitions. The integration of Life Technologies into the Life Sciences Solutions segment provides innovative products and services to customers conducting scientific research and genetic analysis, which enhances the firm’s IT capabilities in supporting business needs. The company’s references to productivity improvements generally refer to improved cost efficiencies from its Practical Process Improvement (PPI) business system, which aligns with the coordination of a firm’s assets and internal processes. The company evaluates segment operating performance using adjusted operating income, which helps management understand and evaluate the segments' core operating results and facilitate comparison of performance for determining compensation. The increase in pro forma revenue at existing businesses was primarily due to increased demand for bioprocess production products as well as biosciences products, reflecting the importance of mobilizing and deploying IT-based resources. The company expects to issue debt in advance of closing the acquisition of Affymetrix to partially fund the acquisition, which will expand the company's existing portfolio of antibodies and assays for high-growth flow cytometry and single-cell biology applications. The company believes that its existing cash and cash equivalents and its future cash flow from operations together with available borrowing capacity will be sufficient to meet the cash requirements of its existing businesses for the foreseeable future. The company’s cash flow from operations totaled $2.82 billion compared with $2.62 billion for the previous year, indicating operational efficiency. The company’s investments in technology and acquisitions are aimed at enhancing its capabilities and supporting business transformation. The company’s management evaluates its estimates, including those related to business combinations and intangible assets, which are critical for assessing the firm’s strategic resources and capabilities. The company’s effective tax rate was favorably affected by adjustments to deferred tax balances due to changes in tax rates, which also reflects the impact of strategic management practices on financial performance. The company recorded restructuring and other costs, net, including charges associated with product liability litigation and third-party transaction and integration costs primarily related to the acquisitions, which are integral to its operational flexibility and strategic resource allocation. The company’s ability to obtain a benefit from lower tax rates outside the U.S. is dependent on its relative levels of income in countries outside the U.S. and on the statutory tax rates in those countries, highlighting the influence of external factors on its financial strategies. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals, thereby enhancing its competitive positioning in the market.